Vrakidou Effimia

Vrakidou Effimia Hematologist

Education & Academic Qualifications

  • Gratuated From Medical School Of National And Kapodistrian University Of Athens

Education:

  • Hematologist (Specialised In ‘Evangelismos’ Hospital)

 

Fellowship in Societies, Membership in Journal Editorial Committees

  • Hellenic Society Of Hematology

  • American Society Of Hematology

  • European Hematology Association

Editorial Boards:
Ad-Hoc Reviewer For Peer-Reviewed International Journals

  • Co-Editor Of Pet/Ct In Lymphomas (Springer)

  • Leading Author Of 2 Chapters In Scientific Magazines (Concerning ‘’Lymphomas’’ And ‘’Mds’’) 

 

Work Experience

  • Associate Member In ‘’Hygeia’’ Hospital.

    • 1986-1990: Working As Independent Doctor Of ‘’Internal Medicine’’

    • 1990-1992: Doctor Of Internal Medicine- Hematologist In ‘’Bio-Check’’

    • 1991-2000: ‘’Hygeia’’ Hospital, Collaborator Hematologist In A. Papagiannis Team

    • 2000-Today: Associate Hematologist Having My Own Hematogical Team

  • Collaboration With Dr. A. Tefferi In Mayo Clinic Rochester

Education Experience:

  • Giving Courses To Post-Graduated Doctors

  • Participation As Tutor In Scientific Events In ‘’Sotiria’’ Hospital’’, ‘’Evangelismos’’ Hospital, ‘’Greek Association Of Pneumology’’,‘’Hygeia’’ Hospital

 

Clinical & Research Interest

Clinical Interest:

  • Leukemia

  • Lymphomas

  • Chronic Myeloproliferative Diseases

  • Thrombophilia

Research Interest:

  • Clinical Studies Concerning ‘’Chronic Lymphocytic Leukemia’’, ‘’Acute Leukemia’’, ‘’Lymphomas’’ (N.H.L. , Hodgkin), ‘’Multiple Myeloma’’, ‘’Myelosclerosis’’

  • Primary Investigator In International Protocols Concerning ‘’Resistant Cll’’ And ‘’Epo’’ 

 

Honors & Awards

  • Scientific Paper On: ‘’R-Chop On The Treatment Of Primary Mediastinal Lym-phoma’’ , Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, And Prednisone With Or Without Radiotherapy In Primary Mediastinal Large B-Cell Lympho-ma: The Emerging Standard Of Care. Pmid: 22282906

Recent Publications

  • Cytotoxic T Cell-Mediated Gastritis After Rituximab Treatment For Gastric Malt Lymphoma. Pmid : 23725385

  • Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, And Prednisone With Or Without Radiotherapy In Primary Mediastinal Large B-Cell Lymphoma: The Emerging Standard Of Care. Pmid: 22282906

  • Association Of Interleukin-1a, Interleukin-1b And Interleukin-1 Receptor An-tagonist Gene Polymorphisms With Multiple Myeloma. Pmid:17926179

  • Pure Infradiaphragmatic Hodgkin’s Lymphoma. Clinical Features, Prognostic Factor And Comparison With Supradiaphragmatic Disease. Pmid:16434368

  • A Randomized Trial Comparing Intensified Cnop Vs. Chop In Patients With Aggressive Non-Hodgkin’s Lymphoma. Pmid: 12769340

 

Ενώνουμε τις δυνάμεις μας για μια νέα εποχή υγείας.

Το site του ΜΗΤΕΡΑ βρίσκεται σε φάση ανανέωσης και μέσα στους επόμενους μήνες θα ενσωματωθεί στο site του ΥΓΕΙΑ (www.hygeia.gr), ώστε να σας προσφέρουμε μια πιο ολοκληρωμένη και ενιαία online εμπειρία.

Σας ευχαριστούμε για την κατανόηση.
Μείνετε συνδεδεμένοι — οι αλλαγές έρχονται σύντομα.